BAM
Baring Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | $486K | Hold |
5,222
| – | – | 0.03% | 165 |
|
|
2017
Q2 | $475K | Hold |
5,222
| – | – | 0.03% | 163 |
|
|
2017
Q1 | $458K | Sell |
5,222
-32,199
| -86% | -$2.82M | 0.03% | 168 |
|
|
2016
Q4 | $3.1M | Hold |
37,421
| – | – | 0.21% | 87 |
|
|
2016
Q3 | $3.46M | Hold |
37,421
| – | – | 0.25% | 82 |
|
|
2016
Q2 | $2.91M | Sell |
37,421
-170
| -0.5% | -$13.2K | 0.24% | 82 |
|
|
2016
Q1 | $3.1M | Hold |
37,591
| – | – | 0.26% | 75 |
|
|
2015
Q4 | $3.94M | Hold |
37,591
| – | – | 0.33% | 73 |
|
|
2015
Q3 | $3.96M | Sell |
37,591
-292
| -0.8% | -$30.8K | 0.36% | 73 |
|
|
2015
Q2 | $5.18M | Hold |
37,883
| – | – | 0.42% | 68 |
|
|
2015
Q1 | $4.72M | Sell |
37,883
-1,816
| -5% | -$226K | 0.37% | 69 |
|
|
2014
Q4 | $3.59M | Sell |
39,699
-22,769
| -36% | -$2.06M | 0.23% | 87 |
|
|
2014
Q3 | $4.51M | Buy |
+62,468
| New | +$4.51M | 0.27% | 87 |
|